Scleromyxedema: Possible association with seminoma

Journal of the American Academy of Dermatology

Volumn 42, Issue 5 II, 2000, Pages 875-878

  Alfadley, Abdullah ^a,b   Al Hoqail, Ibrahim ^a,c   Al Eisa, Abdullah ^a,b  

^a King Faisal Specialist Hosp Res C ^*

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FIBROBLAST; HUMAN; MALE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SCLERODERMA; SEMINOMA;

EID: 0034101080     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(00)90259-7     Document Type: Article

References (20)

1. Gottron HA. Skeleromyxodem. Arch Dermatol Syph 1954;199: 71-91.
2. Dinneen AM, Dicken CH. Scleromyxedema. J Am Acad Dermatol 1995;33:37-43.
3. Milan CP, Cohen LE, Fenske NA, Ling NS. Scleromyxedema:therapeutic response to isotretinoin in three patients. J Am Acad Dermatol 1988;19:469-77.
4. Gabriel SE, Perry HO, Oleson GB, Bowles CA. Scleromyxedema: a scleroderma-like disorder with systemic manifestations. Medicine 1988;67:58-65.
5. Farmer ER, Hambrick GW, Shulman LE. Papular mucinosis, a clinicopathologic study of four patients. Arch Dermatol 1982;118: 9-13.
6. Kubba R, McNeil NI, Rook A. Lichen myxoedematosus, Crohn's disease, and mucinosis ovarian carcinoma. Br J Dermatol 1975; 93(suppl):34-6.
7. Herr HW. Major surgery and scleromyxedema. N Eng J Med 1984;310:788-9.
8. Hill TG, Crawford JN, Rogers CC. Successful management of lichen myxedematosus. Arch Dermatol 1976;112:67-9.
9. Harvey JM, Zilko PJ, Cheah PS, Mastagalia FL, Ojeda VJ. Scleromyxedema and inflammatory myopathy: a clinicopathologic study of three patients. Aust N Z J Med 1986;16:329-35.
10. Alberts AS, Schulz EJ, Geoffrey F, Simson IW, Coccia-Portugal MA. Normalization of skin appearance in a patient with scleromyxedema after invasive chemotherapy for Hodgkin's disease. Dermatologica 1989;178:221-4.
11. Garcia RG, Garcia SG, Vilela DS, Sanchez MJ. Scleromyxedema associated with non-Hodgkin's lymphoma. Int J Dermatol 1989; 28:670-1.
12. Kantor GR, Bergfeld WF, Katzin WE, Reynolds OD, Biscardi AP, Lobur DM, et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14:879-88.
13. Suurmond D, Van Furth R. Scleromyxedema and paraproteinemia. Dermatologica 1969;138:320-7.
14. Muldrow ML, Bailin PL Scleromyxedema associated with IgG lambda multiple myeloma. Cleve Clin Q 1983;50:189-95.
15. Hisler BM, Savoy LB, Hashimoto K. Improvement of scleromyxedema associated with isotretinoin therapy. J Am Acad Dermatol 1991;24:854-7.
16. Howsden SM, Herndon JH, Freeman RG. Lichen myxedema: adermal infiltrative disorder responsive to cyclophosphamide therapy. Arch Dermatol 1975;111:1325-30.
17. Jessen RT, Straight M, Becker LE. Lichen myxedematosus: treatment with cyclophosphamide. Int J Dermatol 1987;17:833-9.
18. Perry HO, Montgomery H, Strickney JM. Further observations on lichen myxedematosus. Ann Intern Med 1960;53:955-69.
19. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurologic syndromes with scleromyxedema. J Am Dermatol 1993;28:105-8.
20. McLean DI. Toward a definition of cutaneous paraneoplastic syndrome. Clin Dermatol 1993;11:11-3.